The CBD retail boom is upon us.

As cannabis-infused products find their way into major retailers, analysts believe the trend will provide a significant catalyst.

"We have seen a high level of interest in cannabis beauty from retailers over the past month based on our store checks and incremental launches. We expect further retailer developments in the coming months,” noted analysts at Piper Jaffray, as quoted by CNBC.

All as people around the world wake up to the health benefits of cannabis, including the treatment of insomnia, stress, anxiety, pain, and even chronic issues.

Inventory turnover is a measure of how efficiently a Company can control its inventory. High turnover is seen as positive by investors as the company does not have much of its working capital tied up in stock.

Canadian LPs need to pass a quality control tests by Health Canada, which requires a third-party lab to test the cannabis to ensure that it is free of contaminates, such as mold, mildew, chemicals, and pesticides before the cannabis can added to inventory. Typically, dried flower has a shelf life of one year, and extracts are longer. Today we have identified four Canadian cannabis stocks with significant inventory positions.

Cannabis plants contain an estimated 113 cannabinoids (THC & CBD are the two that are most well known), each of which may have some medical purposes.

Companies that are spending money on clinical trials could be winners in the long run as there is potential for cannabinoids to be used as an Active Pharmaceutical Ingredient (API), as seen by the FDA approval of GW Pharmaceuticals Epidiolex, for the treatment of seizures.

However, much research still needs to be done to determine the efficacy and safety of cannabis as a medical ingredient. It typically takes a pharmaceutical company 10 years to bring a new drug onto the market.

It’s been a bumpy first few months for cannabis retailers in Canada, with product shortages and regulatory uncertainty dominating public discussion.

As Ontario’s first wave of bricks-and-mortar stores get ready to open on April 1, the Financial Post’s Vanmala Subramaniam spoke to four people on the front lines about what’s working, what isn’t and the biggest lessons they’ve learned so far. The following interviews have been edited and condensed.

***

Krystian Wetulani, a former grey market operator, is the owner of City Cannabis Co. and runs two licensed cannabis stores in Vancouver.

What’s been the biggest problem you’ve encountered so far? 

For National Poison Prevention Week, March 17-23, the Saskatchewan Prevention Institute is cautioning parents to be aware of what their little ones could get into — including their marijuana.

Marijuana has the potential to be dangerous to children if ingested because of their size and weight. Marijuana-laced edibles pose a risk because they can look and taste like their unlaced counterparts. Children could eat a large amount quickly and become ill as a result.  

“The danger with (edibles) is that we don’t know how much THC is in them,” said Dr. Simon Kapaj, a medical health officer with the Saskatchewan Health Authority. “That can be a … concern because children are more sensitive to this harmful substance.”

Zenabis Global Inc. (“Zenabis”)(TSXV:ZENA) announced today that it is now licensed to process and sell cannabis oil products in Canada. The license enables Zenabis to now sell cannabis oil produced at its Atholville, New Brunswick facility, one of the largest indoor cannabis growing facilities in Canada, where Zenabis was already processing oil.

Zenabis expects to market and sell cannabis oil products to its medical clients and to adult use consumers through supply and distribution agreements that Zenabis has in place with nine Canadian jurisdictions including British Columbia, Alberta, Saskatchewan, Quebec, Nova Scotia, New Brunswick, Manitoba, Prince Edward Island, and the Yukon.

The Flowr Corporation (TSX-V:FLWR) (OTC:FLWPF) announced Monday that its FlowrRx products are now available for purchase through Shoppers Drug Mart’s online medical cannabis site.

Cannabis stocks were higher Monday, as investors reacted to the latest tie-ups in the sector and awaited the release of quarterly earnings from Tilray Inc. after the close.

Tilray shares TLRY, -0.36%  were up 0.8%, ahead of the company’s fourth-quarter earnings, which are expected to signal whether or not the company can actually sell pot. The company’s third-quarter numbers came just two weeks after Canada legalized cannabis on Oct. 17, and showed they had not sold any recreational cannabis. Chief Executive Brendan Kennedy has said the fourth quarter would change all that.

Smoking weed will not make hair grow out of your eyes, or out of your ears. It won't make your neck grow to twice its length, and it obviously won't make a new set of ears grow on the top of your head. “But,” goes the crux of a new public education campaign created by the provincial government of Quebec, “the risks are real.”

The hiring spree at Indiva is reflective of the situation playing out at cannabis companies across the country, says the head of the largest marijuana industry association.

“This is a massively growing industry,” said Allan Rewak of the Cannabis Council of Canada, an umbrella group representing some of the country’s largest marijuana companies.

Canada’s cannabis sector employed 11,000 people in December, according to the most recent statistics available, with some projecting that number could hit 150,000 within the next decade, Rewak said.